ELTX · NASDAQ · Biotechnology

Elicio Therapeutics

Develops AMP-enabled cancer immunotherapies centered on the ELI-002 mutant-KRAS program.

$2.80
Pre-market+0.10 (+3.51%)
At close$2.71(−4.75%)

Breakdown13F · 13D/G · Form 4

Institutions53 holders · as of Mar 31, 202613.85%2.64M shares
Insiders6 holders · as of Feb 3, 202652.77%10.06M shares
Strategic holders1 holder · as of Jul 16, 20267.39%1.41M shares
Otherremainder25.99%4.96M shares

19.07M company shares as of Aug 30, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (26.28M in the company's Sep 1, 2026 report, 19.07M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Yekaterina Chudnovsky1Insiderdirector, 10 percent owner
50.65%9.66M13Dfiled Mar 7, 2025
Moti Investments LLCStrategic
7.39%1.41M13Gfiled Jul 16, 2026
Knoll Capital Management, LLCInstitution
3.31%630,91513Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
2.72%518,63813Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution
1.28%244,81413Fas of Mar 31, 2026
Jay VenkatesanInsiderdirector
0.94%179,581Form 4filed Nov 29, 2024
Geode Capital Management, LLCInstitution
0.71%135,16413Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.64%121,63113Fas of Mar 31, 2026
Robert ConnellyInsiderdirector, officer: CEO, President and Director
0.63%120,570Form 4filed Feb 3, 2026
Millennium Management LLCInstitution
0.49%92,76213Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
0.39%74,51213Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
0.37%70,80413Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.36%69,18913Fas of Mar 31, 2026
Northern Trust CorpInstitution
0.31%59,73413Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.30%57,81813Fas of Mar 31, 2026
Christopher HaqqInsiderofficer: See Remarks
0.30%57,381Form 4filed Feb 3, 2026
683 Capital Management, LLCInstitution
0.30%56,44213Fas of Mar 31, 2026
State Street CorpInstitution
0.27%50,62013Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.27%50,59713Fas of Mar 31, 2026
UBS Group AGInstitution
0.18%33,76913Fas of Mar 31, 2026
Morgan StanleyInstitution
0.17%32,40413Fas of Mar 31, 2026
Iridian Asset Management LLC/CTInstitution
0.16%30,05113Fas of Mar 31, 2026
CM Management, LLCInstitution
0.13%25,00013Fas of Mar 31, 2026
Preetam ShahInsiderofficer: See Remarks
0.13%24,000Form 4filed Feb 3, 2026
HRT Financial LPInstitution
0.11%21,61113Fas of Mar 31, 2026
  1. Yekaterina Chudnovsky's transaction reports restate only vehicles that traded; the 2025 ownership statement (9.66M) is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

53 holders · 2.64M shares · 19 new positions · 32 increased · 7 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
Knoll Capital Management, LLC630.9K3.31%0May 15, 2026
Vanguard Capital Management LLC518.6K2.72%+518.6KnewMay 15, 2026
Balyasny Asset Management L.P.244.8K1.28%+106.1KMay 15, 2026
Geode Capital Management, LLC135.2K0.71%+2.6KMay 15, 2026
Renaissance Technologies LLC121.6K0.64%+93.5KMay 14, 2026
Millennium Management LLC92.8K0.49%+92.8KMay 15, 2026
Marshall Wace, LLP74.5K0.39%−42.7KMay 15, 2026
Susquehanna International Group, LLP70.8K0.37%+6.8KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Yekaterina Chudnovsky48.10%9.66M13DMar 7, 2025
Moti Investments LLC6.10%1.41M13GJul 16, 2026
Knoll Capital Management, LLC5.20%630.9K13GFeb 5, 2025

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.